Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 Nov;68(5):831–837. doi: 10.1038/bjc.1993.441

Characterisation of a new mouse monoclonal antibody (ONS-M21) reactive with both medulloblastomas and gliomas.

S Moriuchi 1, K Shimizu 1, Y Miyao 1, T Hayakawa 1
PMCID: PMC1968709  PMID: 8217597

Abstract

We developed an IgG1 mouse monoclonal antibody (ONS-M21) directed against a cell surface antigen of medulloblastomas and gliomas in immunisation of mice with the ONS-76 medulloblastoma cell line. The antibody specifically reacted with medulloblastomas, supratentorial primitive neuroectodermal tumours (SPNETs) and gliomas, but not with other neuroectodermally derived tumours (neuroblastoma and melanoma) or with other kinds of tumours (meningioma, neurinoma, leukaemia, and small cell lung cancer). No reactivity was identified with normal body tissues, including peripheral blood cells. Characterisation of the ONS-M21 antigen showed that it was a trypsin-sensitive glycoprotein with a molecular weight of 80 kDa on SDS-PAGE. The pattern of reactivity and the biochemical properties of this antigen were different from those of other markers of medulloblastoma. These results indicate that ONS-M21 detects a new tumour-associated cell surface antigen specifically expressed by medulloblastomas, SPNETs, and gliomas. This is the first report that medulloblastomas may share common cell surface antigens with gliomas, although most studies have concluded that medulloblastoma has a predominantly neuronal phenotype. The lack of reactivity with normal tissue implies that ONS-M21 has potential applications as both a diagnostic tool and a therapeutic agent.

Full text

PDF
831

Images in this article

833Figure 1
on p.833
834Figure 3
on p.834
834Figure 4
on p.834
835Figure 6
on p.835

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allan P. M., Garson J. A., Harper E. I., Asser U., Coakham H. B., Brownell B., Kemshead J. T. Biological characterization and clinical applications of a monoclonal antibody recognizing an antigen restricted to neuroectodermal tissues. Int J Cancer. 1983 May 15;31(5):591–598. doi: 10.1002/ijc.2910310510. [DOI] [PubMed] [Google Scholar]
  2. Coombes R. C., Buckman R., Forrester J. A., Shepherd V., O'Hare M. J., Vincent M., Powles T. J., Neville A. M. In vitro and in vivo effects of a monoclonal antibody-toxin conjugate for use in autologous bone marrow transplantation for patients with breast cancer. Cancer Res. 1986 Aug;46(8):4217–4220. [PubMed] [Google Scholar]
  3. Dehner L. P. Peripheral and central primitive neuroectodermal tumors. A nosologic concept seeking a consensus. Arch Pathol Lab Med. 1986 Nov;110(11):997–1005. [PubMed] [Google Scholar]
  4. Farwell J. R., Dohrmann G. J., Flannery J. T. Medulloblastoma in childhood: an epidemiological study. J Neurosurg. 1984 Oct;61(4):657–664. doi: 10.3171/jns.1984.61.4.0657. [DOI] [PubMed] [Google Scholar]
  5. Feickert H. J., Pietsch T., Hadam M. R., Mildenberger H., Riehm H. Monoclonal antibody T-199 directed against human medulloblastoma: characterization of a new antigenic system expressed on neuroectodermal tumors and natural killer cells. Cancer Res. 1989 Aug 1;49(15):4338–4343. [PubMed] [Google Scholar]
  6. Gibson F. M., Kemshead J. T. A monoclonal antibody (FMG25) that can differentiate neuroblastoma from other small round-cell tumours of childhood. Int J Cancer. 1987 May 15;39(5):554–559. doi: 10.1002/ijc.2910390503. [DOI] [PubMed] [Google Scholar]
  7. Gross N., Beck D., Carrel S., Munoz M. Highly selective recognition of human neuroblastoma cells by mouse monoclonal antibody to a cytoplasmic antigen. Cancer Res. 1986 Jun;46(6):2988–2994. [PubMed] [Google Scholar]
  8. He X. M., Skapek S. X., Wikstrand C. J., Friedman H. S., Trojanowski J. Q., Kemshead J. T., Coakham H. B., Bigner S. H., Bigner D. D. Phenotypic analysis of four human medulloblastoma cell lines and transplantable xenografts. J Neuropathol Exp Neurol. 1989 Jan;48(1):48–68. doi: 10.1097/00005072-198901000-00005. [DOI] [PubMed] [Google Scholar]
  9. He X. M., Wikstrand C. J., Friedman H. S., Bigner S. H., Pleasure S., Trojanowski J. Q., Bigner D. D. Differentiation characteristics of newly established medulloblastoma cell lines (D384 Med, D425 Med, and D458 Med) and their transplantable xenografts. Lab Invest. 1991 Jun;64(6):833–843. [PubMed] [Google Scholar]
  10. Hershatter B. W., Halperin E. C., Cox E. B. Medulloblastoma: the Duke University Medical Center experience. Int J Radiat Oncol Biol Phys. 1986 Oct;12(10):1771–1777. doi: 10.1016/0360-3016(86)90318-4. [DOI] [PubMed] [Google Scholar]
  11. Jennings M. T., Jennings V. D., Asadourian L. L., Rosenblum M., Albino A. P., Cairncross J. G., Old L. J. Five novel cell surface antigens of CNS neoplasms. J Neurol Sci. 1989 Jan;89(1):63–78. doi: 10.1016/0022-510x(89)90007-5. [DOI] [PubMed] [Google Scholar]
  12. Jones D., Fritschy J., Garson J., Nokes T. J., Kemshead J. T., Hardisty R. M. A monoclonal antibody binding to human medulloblastoma cells and to the platelet glycoprotein IIB-IIIA complex. Br J Haematol. 1984 Aug;57(4):621–631. doi: 10.1111/j.1365-2141.1984.tb02939.x. [DOI] [PubMed] [Google Scholar]
  13. Kemshead J. T., Fritschy J., Garson J. A., Allan P., Coakham H., Brown S., Asser U. Monoclonal antibody UJ 127:11 detects a 220,000-240,000 kdal. glycoprotein present on a sub-set of neuroectodermally derived cells. Int J Cancer. 1983 Feb 15;31(2):187–195. doi: 10.1002/ijc.2910310209. [DOI] [PubMed] [Google Scholar]
  14. Leong A. S., Milios J. Atypical fibroxanthoma of the skin: a clinicopathological and immunohistochemical study and a discussion of its histogenesis. Histopathology. 1987 May;11(5):463–475. doi: 10.1111/j.1365-2559.1987.tb02655.x. [DOI] [PubMed] [Google Scholar]
  15. Moriuchi S., Shimizu K., Yamada M., Mabuchi E., Tamura K., Park K. C., Hayakawa T. Cytotoxic effects of a new antitumor antibiotic, FK973, in malignant glioma. Anticancer Res. 1991 Nov-Dec;11(6):2079–2084. [PubMed] [Google Scholar]
  16. Ogawa A., Sugihara S., Nakanishi Y., Suzuki S., Sasaki A., Hirato J., Nakazato Y. Intermediate filament expression in non-neoplastic pituitary cells. Virchows Arch B Cell Pathol Incl Mol Pathol. 1990;58(5):331–340. doi: 10.1007/BF02890089. [DOI] [PubMed] [Google Scholar]
  17. Okamoto Y., Minamoto S., Shimizu K., Mogami H., Taniguchi T. Interleukin 2 receptor beta chain expressed in an oligodendroglioma line binds interleukin 2 and delivers growth signal. Proc Natl Acad Sci U S A. 1990 Sep;87(17):6584–6588. doi: 10.1073/pnas.87.17.6584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Pastan I., Gottesman M. Multiple-drug resistance in human cancer. N Engl J Med. 1987 May 28;316(22):1388–1393. doi: 10.1056/NEJM198705283162207. [DOI] [PubMed] [Google Scholar]
  19. Raymond W. A., Leong A. S. Oestrogen receptor staining of paraffin-embedded breast carcinomas following short fixation in formalin: a comparison with cytosolic and frozen section receptor analyses. J Pathol. 1990 Apr;160(4):295–303. doi: 10.1002/path.1711600405. [DOI] [PubMed] [Google Scholar]
  20. Reed J. C., Meister L., Tanaka S., Cuddy M., Yum S., Geyer C., Pleasure D. Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin. Cancer Res. 1991 Dec 15;51(24):6529–6538. [PubMed] [Google Scholar]
  21. Rorke L. B., Gilles F. H., Davis R. L., Becker L. E. Revision of the World Health Organization classification of brain tumors for childhood brain tumors. Cancer. 1985 Oct 1;56(7 Suppl):1869–1886. doi: 10.1002/1097-0142(19851001)56:7+<1869::aid-cncr2820561330>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  22. Rorke L. B. The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors. J Neuropathol Exp Neurol. 1983 Jan;42(1):1–15. [PubMed] [Google Scholar]
  23. Tachibana I., Watanabe M., Tanio Y., Hayashi S., Hosoe S., Saito S., Matsunashi M., Osaki T., Shigedo Y., Masuno T. Generation of a small cell lung cancer variant resistant to lymphokine-activated killer (LAK) cells: association with resistance to a LAK cell-derived, cytostatic factor. Cancer Res. 1992 Jun 15;52(12):3310–3316. [PubMed] [Google Scholar]
  24. Takahashi H., Belser P. H., Atkinson B. F., Sela B. A., Ross A. H., Biegel J., Emanuel B., Sutton L., Koprowski H., Herlyn D. Monoclonal antibody-dependent, cell-mediated cytotoxicity against human malignant gliomas. Neurosurgery. 1990 Jul;27(1):97–102. doi: 10.1097/00006123-199007000-00013. [DOI] [PubMed] [Google Scholar]
  25. Tamura K., Shimizu K., Yamada M., Okamoto Y., Matsui Y., Park K. C., Mabuchi E., Moriuchi S., Mogami H. Expression of major histocompatibility complex on human medulloblastoma cells with neuronal differentiation. Cancer Res. 1989 Oct 1;49(19):5380–5384. [PubMed] [Google Scholar]
  26. Tanio Y., Watanabe M., Inoue T., Kawase I., Shiraska T., Ikeda T., Hara H., Masuno T., Saito S., Kawano K. Chemo-radioresistance of small cell lung cancer cell lines derived from untreated primary tumors obtained by diagnostic bronchofiberscopy. Jpn J Cancer Res. 1990 Mar;81(3):289–297. doi: 10.1111/j.1349-7006.1990.tb02563.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Trojanowski J. Q., Friedman H. S., Burger P. C., Bigner D. D. A rapidly dividing human medulloblastoma cell line (D283 MED) expresses all three neurofilament subunits. Am J Pathol. 1987 Feb;126(2):358–363. [PMC free article] [PubMed] [Google Scholar]
  28. Wakabayashi T., Yoshida J., Seo H., Kazo K., Murata Y., Matsui N., Kageyama N. Characterization of neuroectodermal antigen by a monoclonal antibody and its application in CSF diagnosis of human glioma. J Neurosurg. 1988 Mar;68(3):449–455. doi: 10.3171/jns.1988.68.3.0449. [DOI] [PubMed] [Google Scholar]
  29. Wikstrand C. J., McLendon R. E., Bullard D. E., Fredman P., Svennerholm L., Bigner D. D. Production and characterization of two human glioma xenograft-localizing monoclonal antibodies. Cancer Res. 1986 Nov;46(11):5933–5940. [PubMed] [Google Scholar]
  30. Zimmermann U. Electric field-mediated fusion and related electrical phenomena. Biochim Biophys Acta. 1982 Nov 30;694(3):227–277. doi: 10.1016/0304-4157(82)90007-7. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES